ALX Oncology (ALXO) vs Emmis Acquisition (EMIS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
ALX Oncology is the larger company by market cap ($163.2 million vs $162.0 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALXO | EMIS |
|---|---|---|
| Share price | $1.18 | $10.27 |
| Market cap | $163.17M | $162.02M |
| 1-day change | +4.42% | 0.00% |
| YTD return | 0.00% | +3.22% |
| 1-year return | -38.25% | — |
| 5-year return | -98.08% | — |
| EPS (TTM) | $-1.13 | — |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.66 | $10.27 |
| 52-week low | $1.05 | $9.90 |
| Distance from 52-week high | -55.64% | 0.00% |
| Analyst consensus | none | — |
| Avg. price target upside | +289.83% | — |
| Average volume | 1.02M | 13.67K |
| Shares outstanding | 138.28M | 11.94M |
| Employees | 48 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About ALX Oncology
ALXO stock →ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. The company's lead product candidate is Evorpacept, a CD47 blocking therapeutic biologic development as a combination therapy with other anti-cancer agents, including ASPEN-06, under phase 2 clinical study for treating Gastric/GEJ cancer.
Health Care · Biotechnology: Pharmaceutical Preparations · 48 employees
About Emmis Acquisition
EMIS stock →Emmis Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
Health Care · Biotechnology: Pharmaceutical Preparations
ALXO vs EMIS FAQ
Which is bigger, ALX Oncology or Emmis Acquisition?
ALX Oncology (ALXO) is larger, with a market capitalization of $163.17M compared with $162.02M for Emmis Acquisition (EMIS).
Are ALX Oncology and Emmis Acquisition in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.